Wen-chun Hung

Title: The Innovations of Wen-chun Hung

Introduction

Wen-chun Hung is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors involved in vascular growth.

Latest Patents

Wen-chun Hung holds a patent for "Dual-function antibodies targeting VEGFR2 and VEGFR3." This patent describes an isolated antibody that comprises heavy chain complementary determining regions CDR1, CDR2, and CDR3 from a heavy chain variable region sequence having SEQ ID NO: 1 or 3. It also includes light chain complementary determining regions CDR1, CDR2, and CDR3 from a light chain variable region sequence having SEQ ID NO: 2 or 4. The antibody binds specifically to both vascular endothelial growth factor receptor-2 (VEGFR2) and vascular endothelial growth factor receptor-3 (VEGFR3). This innovation has the potential to advance therapeutic strategies in treating various diseases.

Career Highlights

Wen-chun Hung is affiliated with the National Health Research Institutes, where he conducts research and develops innovative solutions in health and medicine. His work has garnered attention for its potential impact on healthcare.

Collaborations

Wen-chun Hung collaborates with esteemed colleagues, including Neng-Yao Shih and Ko-Jiunn Liu. Their combined expertise contributes to the advancement of research in their field.

Conclusion

Wen-chun Hung's contributions to biotechnology, particularly through his patent on dual-function antibodies, highlight his role as an innovator in the medical research community. His work continues to pave the way for advancements in therapeutic applications.